Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Phase II Study Investigating Efficacy of Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

NCT03273374 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT03273374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03273374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Phase II Study Investigating Efficacy of Intraoperative Radiation Therapy for Resectable Pancreatic Cancer
Lead sponsor
Gangnam Severance Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 14, 2017
Completion date
August 22, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable pancreatic adenocarcinoma